PharVision Advisers’s Sysco SYY Stock Holding History

PharVision Advisers’s Portfolio SYY Stock Details SYY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,695	Closed	-$420K	–	580
2025 Q4	$420K	Buy	+5,695	New	+$433K	0.21%	100
2025 Q2	–	Sell	-3,667	Closed	-$275K	–	424
2025 Q1	$275K	Buy	+3,667	New	+$269K	0.38%	112

Other funds holding SYY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's SYY Position: Q1 2026 in Review

PharVision Advisers sold out of Sysco (SYY) in Q1 2026, closing a stake of 5,695 shares — an estimated $420K sold.

PharVision Advisers first reported a position in SYY in Q1 2025 and held it in 2 quarters. The position peaked at $420K in Q4 2025. 1,560 funds tracked by Wall St. Rank hold SYY as of Q1 2026.

PharVision Advisers reported no remaining Sysco position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 5,695 Sysco shares in Q1 2026, an estimated $420K.
PharVision Advisers first reported a position in Sysco in Q1 2025 and held it in 2 quarters.
PharVision Advisers's Sysco position peaked at $420K in Q4 2025.
1,560 funds tracked by Wall St. Rank held Sysco as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.